Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

Abstract Background Atrophic acne scarring often accompanies acne vulgaris. The efficacy of topical retinoids for treatment of acne is well documented; however, evidence for use in atrophic acne scars is limited. Methods In this randomized, split-face, double-blind study, subjects (age: 17–34 years,...

Full description

Bibliographic Details
Main Authors: Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson, Sunil Dhawan, Rajeev Chavda, J. P. York, Baldo Sforzolini, Kate Holcomb, Glynis Ablon, James Del Rosso, Brigitte Dreno
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-10-01
Series:Dermatology and Therapy
Subjects:
Acne vulgaris
Atrophic scar
Clinical study
Trifarotene
Online Access:https://doi.org/10.1007/s13555-023-01042-7

Internet

https://doi.org/10.1007/s13555-023-01042-7

Similar Items